Lucia Leccisotti

Medicine and Dentistry

1. Patient 100%
2. PET-CT 66%
3. Positron Emission Tomography 34%
4. Fluorodeoxyglucose F 18 27%
5. Inpatient 27%
6. Computed Tomography 26%
7. Rectum Cancer 26%
8. Therapeutic Procedure 23%
9. Positron Emission Tomography-Computed Tomography 20%
10. Diagnosis 19%
11. Carcinoid 18%
12. Mucinous Carcinoma 18%
13. Neoplasm 17%
14. Magnetic Resonance Imaging 17%
15. Metastatic Carcinoma 17%
16. Diseases 16%
17. Chemoradiotherapy 16%
18. Dapagliflozin 15%
19. Non Small Cell Lung Cancer 14%
20. Glucose Uptake 14%
21. Lung 14%
22. Recurrent Disease 13%
23. Sodium Glucose Cotransporter 2 Inhibitor 12%
24. Heart Muscle Perfusion 11%
25. Lesion 11%
26. Assessment 11%
27. Coronary Circulation 10%
28. Follow up 10%
29. Fluorodeoxyglucose 10%
30. Cardiovascular System 10%
31. Glucose 10%
32. Age 10%
33. Autologous Peripheral Blood Stem Cell Transplantation 10%
34. Primary Tumor 9%
35. Patient with Type 2 Diabetes 9%
36. Evaluation Study 9%
37. Chemoradiation Therapy 9%
38. Overall Survival 8%
39. Acute Coronary Syndrome 7%
40. Syndrome 7%
41. Adipose Tissue 7%
42. Coronary Artery Disease 7%
43. Maturity Onset Diabetes of the Young 7%
44. Quantitative Analysis 7%
45. Thyroid Nodule 7%
46. Gallium 68 7%
47. Calcitonin 7%
48. Analysis 6%
49. Man 6%
50. Distant Metastasis 6%